Abstract
To assess access to insulin delivery devices and HbA1c in 41 countries supported by the Life for a Child (LFAC) program Syringes (83.1%), insulin pens (16.7%) and pumps (0.2%) were used for insulin delivery If supplies were not donated, there was variable access to HbA1c testing within public health facilities and cost was usually covered by the patient
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
